ArticleFrontiers in pharmacology2022

Combination Therapy of Alpha-Lipoic Acid, Gliclazide and Ramipril Protects Against Development of Diabetic Cardiomyopathy

George J Dugbartey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.